These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7045778)

  • 1. [In vitro study of the susceptibility of mycobacteria to sulfonamides by the disc and percentage methods (author's transl)].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1982 Apr; 30(4):201-5. PubMed ID: 7045778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiogram of mycobacteria for erythromycin, tetracycline and cotrimoxazole].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1983 Mar; 31(3):195-7. PubMed ID: 6343976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
    Tsukamura M
    Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance behavior of atypical mycobacteria to antibiotics and sulfonamides].
    Neubert R
    Z Erkr Atmungsorgane; 1986; 167(1-2):47-51. PubMed ID: 3765715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of mycobacteria to dapsone.
    Portaels F; Van den Breen L; Pattyn SR
    Arzneimittelforschung; 1982; 32(9):1124-5. PubMed ID: 6890836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relative relatedness of 11 mycobacteria species by microplate hybridization methods considering delta Tm].
    Fukasawa Y
    Kekkaku; 2002 Aug; 77(8):547-54. PubMed ID: 12235846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. College of American Pathologists Mycobacteriology E Proficiency Testing Survey. Summary of participant performance, 1979-1992.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1995 Jan; 119(1):17-22. PubMed ID: 7802547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of atypical mycobacteria isolated from clinical specimens by line probe assay (LIPA)].
    Biçmen C; Coşkun M; Gündüz AT; Senol G; Cirak AK; Tibet G
    Mikrobiyol Bul; 2007 Oct; 41(4):503-10. PubMed ID: 18173068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method to differentiate between Mycobacterium tuberculosis and non-tuberculous mycobacteria directly on clinical specimens.
    Varma-Basil M; Kumar S; Yadav J; Kumar N; Bose M
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):111-4. PubMed ID: 17539255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.